Geneviève Fortier
Chief Executive Officer
Geneviève Fortier will be available to meet on the following dates:
Thursday, April 30, 2026, from 10 to 11 a.m.
Thursday, May 21, 2026, from 2 to 4 p.m.
Professional background
Geneviève Fortier has been serving as Chief Executive Officer of Promutuel Insurance since 2019, becoming the first woman to hold this role in the company’s 170+ year history.
Recipient of numerous honors, Geneviève Fortier was awarded the title of « Grande diplômée » by Université Laval in 2025. She was also named CEO of the Year 2024 by Les Affaires in the Large Enterprise category and recognized among the Top 20 Most Dynamic CEOs in Canada in 2021. In June 2023, she was also appointed to the National Order of Quebec, the highest distinction awarded by the Quebec government.
A seasoned governance expert, Geneviève is Chair of the Board of Directors at Investissement Québec and a board member of METRO Inc. and Équité Association. Until recently, she was also Chair of the Canadian Association of Mutual Insurance Companies (CAMIC) and Chair of the Insurance Bureau of Canada's Quebec Chapter. Deeply committed to community engagement, she actively supports young people and women in achieving their career aspirations.
The company
Proud of its history, Promutuel Insurance has been one of Quebec’s largest property and casualty insurers for nearly 175 years. Driven by a modern and effective mutual model, it is fully committed to ensuring the well-being and peace of mind of its 653,000 insured members, its 2,400 employees, and its communities by relying on solidarity, openness, commitment, and ambition to guide its decisions, actions, and collaborations.
With $2.1 billion in assets, Promutuel Insurance has a solid financial foundation that allows it to support its mission with rigor and vision. Reflecting its convictions, the future that inspires it is both bold and deeply human: to become an engaged and responsible Canadian leader, the insurer people choose for its values.
Expenses related to this virtual initiative are minimal. Nearly all revenues generated are donated to the IRCM Foundation, whose mission is to support basic and clinical research at the Institut de recherches cliniques de Montréal (IRCM).
Researchers at the IRCM, grouped around 4 major themes, are working to deepen our knowledge of almost all the major diseases of our time: cancer, diabetes, cardiovascular, genetic or inflammatory diseases, Alzheimer's and Parkinson's, to name but a few. Physicians at the IRCM Clinic care for patients living with complex or rare diseases that require ultra-specialized follow-up.
